Join the Breast Cancer - Adjuvant group to help and get support from people like you.
Breast Cancer - Adjuvant News (Page 9)
Use of AI Plus One Radiologist Noninferior for Detecting Breast Cancer
MONDAY, Sept. 18, 2023 – Double reading of screening mammograms by one radiologist plus artificial intelligence (AI) is noninferior to standard-of-care double reading by two radiologists, according...
Diet, Exercise Intervention May Aid Chemotherapy Outcomes in Breast Cancer
FRIDAY, Sept. 15, 2023 – A home-based diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer, according to a study published online Sept. 1 in the...
Interventions Can Increase Adjuvant Endocrine Treatment Adherence
THURSDAY, Sept. 14, 2023 – Lowering medication costs and some psychosocial and reminder interventions show the most promise for promoting adjuvant endocrine therapy (AET) adherence in breast cancer...
Dirty Air Could Raise Breast Cancer Risk
WEDNESDAY, Sept. 13, 2023 – Air pollution has long been known to harm the heart and lungs, but new research suggests it might also raise the risk of breast cancer. Researchers at the U.S. National...
Fine Particular Matter Linked to Increase in Breast Cancer Risk
TUESDAY, Sept. 12, 2023 – Fine particulate matter (PM2.5) is associated with an increased risk for breast cancer, specifically estrogen receptor-positive (ER+) breast cancer, according to a study...
Diagnostic Performance of AI Comparable to Humans for Mammograms
WEDNESDAY, Sept. 6, 2023 – Diagnostic performance of an artificial intelligence (AI) algorithm is comparable to human reader performance for interpreting mammographic screening, according to a study...
AI Equals Human Radiologists at Interpreting Breast Cancer Scans
TUESDAY, Sept. 5, 2023 – Another study is showing that artificial intelligence (AI) is as good as a specialist doctor in spotting breast cancer on a mammogram. But don't expect computers to take...
Combined AI, Mammography Texture Model Improves Breast CA Risk Prediction
TUESDAY, Aug. 29, 2023 – Combining artificial intelligence (AI) with mammography texture models improves breast cancer risk assessment, according to a study published online Aug. 29 in Radiology....
AI-Assisted Mammograms Could Be a Big Advance: Study
WEDNESDAY, Aug. 2, 2023 – Artificial intelligence (AI) programs can safely be used to help radiologists review mammogram images and detect breast cancers, early results from an ongoing clinical...
Racial Disparities Seen for Cost of Unplanned Care After Breast Reconstruction
WEDNESDAY, Aug. 2, 2023 – While race is not a significant predictor of unplanned hospital visits after breast reconstruction surgery, racial minorities bear a higher cost burden than White breast...
Mammography Plus Ultrasound Superior to Mammography With AI for Dense Breasts
TUESDAY, Aug. 1, 2023 – Mammography with supplementary ultrasound has higher accuracy and a lower recall rate than mammography with artificial intelligence (AI) or mammography with ultrasound and...
New Ultrasound Patch Spots Tiny Breast Abnormalities in Early Trial
FRIDAY, July 28, 2023 – Scientists have developed a wearable ultrasound patch that might eventually allow women to monitor themselves for early signs of breast cancer in the comfort of their home....
Biological Aging Accelerated With Breast Cancer Diagnosis, Treatment
TUESDAY, July 25, 2023 – Breast cancer diagnosis and treatment is associated with accelerated biological aging, according to a study published online July 19 in the Journal of the National Cancer...
FDA Approves Genentech’s Perjeta (Pertuzumab) for Adjuvant Treatment of Specific Type of Early Breast Cancer
South San Francisco, CA – December 20, 2017 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has approved Perjeta ® ...
FDA Approves Nerlynx (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer
July 17, 2017 – The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type...
Ask a question
To post your own question to this support group, sign in or create an account.